Sleep deprivation and fat cells linked to diabetes risk

Sleep restriction drives up diabetes risk by increasing insulin resistance in fat cells, US researchers say.

Sleep deprivation linked to increased diabetes risk
Sleep deprivation linked to increased diabetes risk

A University of Chicago team led by Dr Matthew Brady studied the effect of sleep restriction on insensitivity in human subcutaneous fat cells.

Dr Brady and his team asked seven volunteers to sleep for either four hours a night for four consecutive nights, or 8.5 hours a night for the same period.

The order in which volunteers undertook these two interventions was randomised.

The researchers then took biopsies of fat cells and looked at how well the cells responded to exposure to increasing insulin concentrations.

They looked at the ability of insulin to raise levels of phosphorylated protein kinase B, a key part of the insulin-signalling pathway.

Dr Brady and his team found a 30% reduction in cellular insulin sensitivity in adipocyte cells collected following sleep restriction.

They said the study provided 'additional evidence that insufficient sleep may contribute to the development of, or exacerbate, metabolic disorders'.

'To our knowledge, this finding identifies for the first time a molecular mechanism that may be involved in the reduction in total body insulin sensitivity consistently observed in multiple laboratory studies of partial sleep deprivation in healthy adults, as well as in the participants of our study,' they said.

Dr Brady and his colleagues said research should now look at the therapeutic relevance of the finding. 'Future studies are needed to determine whether optimising sleep duration may delay the development, or reduce the severity, of metabolic alterations in persons at increased risk for diabetes,' they said.

Additional trials also need to look at whether 'maintaining sufficient sleep duration may be an important behavioural modification, in conjunction with a healthy diet and exercise, to prevent and treat obesity and diabetes', they said.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Under 40s to be offered alternative to AstraZeneca COVID-19 vaccine

Under 40s to be offered alternative to AstraZeneca COVID-19 vaccine

Patients aged 30-39 will be offered an alternative to the Oxford/AstraZeneca COVID-19...

GPs per patient down 10% in just five years, NHS data reveal

GPs per patient down 10% in just five years, NHS data reveal

The number of fully-qualified, full-time equivalent (FTE) GPs per patient in England...

Supportive model must replace harmful CQC inspections, BMA chair warns

Supportive model must replace harmful CQC inspections, BMA chair warns

CQC inspections that ‘divert time away from patient care’ and ‘instil fear’ among...

UK COVID-19 vaccination programme tracker

UK COVID-19 vaccination programme tracker

GPs across the UK are playing a leading role in the largest-ever NHS vaccination...

A 'tsunami' of work is drowning general practice: GPs speak out about a profession at its limit

A 'tsunami' of work is drowning general practice: GPs speak out about a profession at its limit

Rocketing workloads created by huge backlogs of cases and continuing COVID-19 disruption...

Slight increase in GP workforce during past year, but number of partners continues to fall

Slight increase in GP workforce during past year, but number of partners continues to fall

The GP workforce grew by 0.4% in the year to March 2021, but the number of GP partners...